Wikidata

(Q61981220)

English

A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
MISSION (English)
0 references
title
A Phase III, Multi-center, Placebo-Controlled Trial of Sorafenib (BAY43-9006) in Patients With Relapsed or Refractory Advanced Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC) After 2 or 3 Previous Treatment Regimens for Advanced Disease (English)
0 references
sponsor
Bayer
0 references
country
Argentina
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
India
0 references
Indonesia
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Pakistan
0 references
Peru
0 references
Philippines
0 references
Poland
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Taiwan
0 references
Thailand
0 references
Turkey
0 references
United Kingdom
0 references
start time
April 2009
0 references
end time
March 2012
0 references
number of participants
703
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61981220&oldid=2232344151"